Compare JPMorgan Diversified Return International Eqty ETF (JPIN) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Diversified Return International Eqty ETF vs Tenet Healthcare Corporation — how do they compare? JPMorgan Diversified Return International Eqty ETF trades at $76.97, while Tenet Healthcare Corporation trades at $262.96 (market cap $20.89B). Which is the better fit depends on your goals.
| JPIN | THC | |
|---|---|---|
52-Week High | $77.00 | $262.63 |
52-Week Low | $64.96 | $161.37 |
Market Cap | — | $20.89B |
Sector | — | Health |
Enterprise Value | — | $31.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JPIN, the JPMorgan Diversified Return International Equity ETF, trades at $76.97, up 0.8% on the day, with a bullish technical signal driven by moving averages. The ETF provides broad exposure to foreign large-cap value stocks. Key technical indicators show overbought conditions with RSI levels above 74, while the ADX indicates a strong trend. A dividend of $0.91 per share is scheduled for payment in June 2026.
The outlook for JPIN is supported by its smart beta strategy targeting international value equities, though overbought technicals suggest near-term consolidation risk. Investment appeal lies in diversified global exposure, but risks include currency fluctuations and international market volatility. The absence of current fundamental data limits valuation assessment, requiring reliance on technical and sentiment indicators.
Tenet Healthcare (THC) trades at $260.67, up 0.28% today, with strong technical momentum including a golden cross pattern and bullish moving average alignment. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $6.12 versus $4.26 forecast, maintaining a three-quarter earnings beat streak. Valuation metrics remain attractive with P/E of 10.03 and EV/EBITDA of 5.73, while profitability metrics show exceptional ROE of 53.31% and net margin of 9.9%.
The investment outlook remains positive with 81% analyst buy ratings and $281.44 consensus price target representing 8% upside. Key risks include policy headwinds in ACA exchanges and hospital segment challenges, though strong ambulatory growth provides offset. The stock presents a compelling value-growth combination with momentum characteristics, supported by institutional accumulation and positive earnings revisions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About JPMorgan Diversified Return International Eqty ETF
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
